Scinai Immunotherapeutics Celebrates Dr. Lotti's Award for PC111 Research in Italian Dermatology
Scinai Immunotherapeutics Celebrates Research Breakthrough in Autoimmunity
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a leader in biopharmaceuticals focused on inflammation and immunology, is making headlines following the prestigious recognition of Dr. Roberta Lotti. Dr. Lotti, a key researcher at the Italian biotech firm Pincell Srl, has been awarded the
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.